{"latest_checked": "2026-08-13T04:33:12.746470+00:00", "coverage_count": 5070, "recent_count": 15, "transaction_limit": 160, "filters": {"q": "", "ticker": "BCYC", "sector": "", "industry": "", "side": "", "start": "2026-06-30", "end": "2026-08-14"}, "summary": {"total": 15, "acquisition_count": 4, "disposal_count": 11, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 60460.98, "disposal_value_label": "$60.5K", "net_value": -60460.98, "net_value_label": "$-60.5K", "flow_tone": "negative", "largest_value_label": "$25.2K", "top_sector": "Healthcare", "window_label": "30 Jun 2026 to 14 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 15, "value": "60460.9800", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$60.5K"}], "days": [{"transaction_date": "2026-07-02", "acquisitions": 0, "disposals": 5, "total": 5, "bar_width": 83.3}, {"transaction_date": "2026-07-06", "acquisitions": 0, "disposals": 6, "total": 6, "bar_width": 100.0}, {"transaction_date": "2026-07-15", "acquisitions": 4, "disposals": 0, "total": 4, "bar_width": 66.7}], "side_mix": {"acquisitions": 4, "disposals": 11, "acquisition_share": 26.7, "disposal_share": 73.3}}, "company_flows": [{"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-06", "acquisitions": 0, "disposals": 11, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 60460.98, "disposed_value_label": "$60.5K", "net_value": -60460.98, "net_value_label": "$-60.5K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}], "company_overview": [{"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-15", "filings": 15, "acquisitions": 4, "disposals": 11, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 60460.98, "disposed_value_label": "$60.5K", "net_value": -60460.98, "net_value_label": "$-60.5K", "acquisition_share": 26.7, "disposal_share": 73.3, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}], "transactions": [{"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "HANNAY, MICHAEL CHARLES FERGUSON", "executive_title": "CHIEF PROD & SUPPLY CHAIN OFF", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 60000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-08-05T22:08:02.245176+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "PERRY, JENNIFER SCOTT", "executive_title": "Chief Operating Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 60000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-08-05T22:08:02.251411+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "SKYNNER, MICHAEL", "executive_title": "CHIEF SCIENTIFIC OFFICER", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 60000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-08-05T22:08:02.247499+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "THOMPSON, TRAVIS ALVIN", "executive_title": "Chief Financial Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 60000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context", "fetched_at": "2026-08-05T22:08:02.249414+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "LEE, KEVIN", "executive_title": "Director, CHIEF EXECUTIVE OFFICER", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 1737.0, "share_price": 4.31, "transaction_value": 7486.47, "transaction_value_label": "$7.5K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-24T11:09:45.294100+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "SKYNNER, MICHAEL", "executive_title": "CHIEF SCIENTIFIC OFFICER", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 532.0, "share_price": 4.31, "transaction_value": 2292.92, "transaction_value_label": "$2.3K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-24T11:09:45.298106+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "PERRY, JENNIFER SCOTT", "executive_title": "Chief Operating Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 333.0, "share_price": 4.34, "transaction_value": 1445.22, "transaction_value_label": "$1.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-24T11:09:45.290964+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "HANNAY, MICHAEL CHARLES FERGUSON", "executive_title": "CHIEF PROD & SUPPLY CHAIN OFF", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 255.0, "share_price": 4.31, "transaction_value": 1099.05, "transaction_value_label": "$1.1K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-24T11:09:45.296023+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "THOMPSON, TRAVIS ALVIN", "executive_title": "Chief Financial Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 104.0, "share_price": 4.31, "transaction_value": 448.24, "transaction_value_label": "$448", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-24T11:09:45.288846+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "PERRY, JENNIFER SCOTT", "executive_title": "Chief Operating Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 43.0, "share_price": 4.31, "transaction_value": 185.33, "transaction_value_label": "$185", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-24T11:09:45.292666+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "LEE, KEVIN", "executive_title": "Director, CHIEF EXECUTIVE OFFICER", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 5905.0, "share_price": 4.27, "transaction_value": 25214.35, "transaction_value_label": "$25.2K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-22T21:58:51.784527+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "SKYNNER, MICHAEL", "executive_title": "CHIEF SCIENTIFIC OFFICER", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 1859.0, "share_price": 4.27, "transaction_value": 7937.93, "transaction_value_label": "$7.9K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-22T21:58:51.777521+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "HANNAY, MICHAEL CHARLES FERGUSON", "executive_title": "CHIEF PROD & SUPPLY CHAIN OFF", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 1506.0, "share_price": 4.27, "transaction_value": 6430.62, "transaction_value_label": "$6.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-22T21:58:51.782226+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "PERRY, JENNIFER SCOTT", "executive_title": "Chief Operating Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 1036.0, "share_price": 4.27, "transaction_value": 4423.72, "transaction_value_label": "$4.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-22T21:58:51.778801+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}, {"symbol": "BCYC", "name": "Bicycle Therapeutics Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-02", "executive": "THOMPSON, TRAVIS ALVIN", "executive_title": "Chief Financial Officer", "security_type": "Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 819.0, "share_price": 4.27, "transaction_value": 3497.13, "transaction_value_label": "$3.5K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Directional", "fetched_at": "2026-07-22T21:58:51.780814+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/bcyc/", "research_links": {"chart": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/", "report": "/terminal/7063861a-0d6e-4680-905a-c88f8f7143ee/report/", "factor": "/factors/ticker/7063861a-0d6e-4680-905a-c88f8f7143ee/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}